Huiling Lü

65 papers receiving 1.9k citations

Huiling Lü's Hit Papers

Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial 2012 · 500 citations
5000+4+9Years since publication100200300400500

Peers

Huiling Lü
Comparison fields: 5 of 124
  • Microbiology 33
  • Endocrine and Autonomic Systems 143
  • Oncology 561
  • Immunology 398
  • Epidemiology 540
Replace Kathleen G. Dickman with:
Kathleen G. Dickman United States
Bok-Soo Lee South Korea
Guoyong Hu China
Alessia Perino Italy
Anne M. Latour United States
Sungsoon Fang South Korea
Jun Shi China
Marianne Böni‐Schnetzler Switzerland
Tania Romacho Spain
Jean Y. Park United States
Huiling Lü relative to Kathleen G. Dickman United States Kathleen G. Dickman's profile →
Citations per field
00.5×11×
Kathleen G. Dickman · 1×
Citations per year

Countries citing papers authored by Huiling Lü

Since Specialization
Citations

This map shows the geographic impact of Huiling Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiling Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiling Lü more than expected).

Fields of papers citing papers by Huiling Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiling Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiling Lü. The network helps show where Huiling Lü may publish in the future.

Co-authors

The 25 scholars most cited alongside Huiling Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Huiling Lü Line = papers co-authored together Huiling Lü links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial
Hit paper breakdown →
2012500
2 200580
3 201879
4 201975
5 200766
6 200665
7 201061
8 200658
9 202257
10 200550
11 200746
12 200544
13 200544
14 202142
15 201238
16 201938
17 201237
18 201834
19 201831
20 201728

About Huiling Lü

Huiling Lü is a scholar working on Epidemiology, Molecular Biology, Physiology, Pharmacology and Endocrine and Autonomic Systems, having authored 66 papers that have together received 2.0k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (16 papers), Adipose Tissue and Metabolism (12 papers), Apelin-related biomedical research (7 papers), Regulation of Appetite and Obesity (7 papers), Neuropeptides and Animal Physiology (4 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Receptor Mechanisms and Signaling (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Microbiology (33 citations), Endocrine and Autonomic Systems (143 citations), Oncology (561 citations), Immunology (398 citations) and Epidemiology (540 citations). Huiling Lü has collaborated with scholars based in China, Canada and Japan. Frequent co-authors include Piotr Serwatowski, Martin Reck, Thomas J. Lynch, Alexander Luft, Igor Bondarenko, Raju Titus Chacko, Jean-Marie Cuillerot, Martin Sebastian, Fabrice Barlési and Katherine Cianflone. Their work appears in journals such as Journal of Cellular Biochemistry, PLoS ONE, Medicine, Oncology Reports and American Journal of Physiology-Gastrointestinal and Liver Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact